Next is superficial pyoderma, which clinicians see most often. Signs include folliculocentric pustules and spreading crusts; hair often becomes trapped in the crust and falls out. Clients often do not ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...
Tralokinumab-ldrm is approved for the treatment of moderate-to-severe AD in adult and adolescent patients 12 years and older in the European Union, Canada, Great Britain, the United Arab Emirates, ...
Christina Gentry, DVM, DACVM, shared a key dermatology takeaway from her co-presented CE session on concurrent disease.
Although it looked to be lights out for InflaRx’s C5a antibody vilobelimab in the rare skin disorder pyoderma gangrenosum (PG) last year, the German drugmaker ended 2025 with a glimmer of hope for the ...
Gastroenterology specialists Dr Andy Li and Dr Jessica Gurung outline a rational approach to investigating recurrent ...
We report a rare case of concurrent cutaneous and prostatic pyoderma gangrenosum (PG) in a man in his 70s. The patient initially presented with dysuria, pelvic discomfort and a boggy prostate, ...
Pyoderma gangrenosum (PG) is a rare, non-infective ulcerating skin disorder commonly associated with systemic inflammatory or haematological conditions. This report highlights two postpartum cases of ...
No Name Club were among the many groups to pay tribute to Edith Geraghty from Belmullet who passed away following an illness ...
The global Canine Urolithiasis Treatment Market is positioned for sustained expansion over the next decade as pet owners and ...
The global Canine Urolithiasis Treatment Market is positioned for sustained expansion over the next decade as pet owners and veterinary professionals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results